Results 281 to 290 of about 163,643 (341)
Some of the next articles are maybe not open access.

Primary open-angle glaucoma

Nature Reviews Disease Primers, 2016
Glaucoma is an optic neuropathy that is characterized by the progressive degeneration of the optic nerve, leading to visual impairment. Glaucoma is the main cause of irreversible blindness worldwide, but typically remains asymptomatic until very severe.
R. Weinreb   +6 more
semanticscholar   +5 more sources

Open-Angle Glaucoma

Primary Care: Clinics in Office Practice, 1989
Open-angle glaucoma is a common cause of blindness and visual impairment, and is characterized by elevated intraocular pressure, optic nerve degeneration and visual field loss. Risk factors include increasing age, black race, positive family history and diabetes.
K L, Margolis, E C, Rich
openaire   +2 more sources

Primary open‐angle glaucoma

Medical Journal of Australia, 2002
Early diagnosis of this otherwise progressive, asymptomatic process is essential.
Ivan, Goldberg   +2 more
openaire   +2 more sources

Therapy for Open-Angle Glaucoma

The Consultant Pharmacist, 2018
Review the clinical manifestations and treatment of primary open-angle glaucoma (POAG).Articles indexed in PubMed, Scopus, and Cochrane Library in the last 10 years using the key words "glaucoma," "open-angle glaucoma," and "'open-angle glaucoma' AND 'treatment.'" Primary sources were used to locate additional resources. ClinicalTrials. gov was used to
Leisa L, Marshall   +2 more
openaire   +2 more sources

XEN implant in primary and secondary open-angle glaucoma: A 12-month retrospective study

European Journal of Ophthalmology, 2020
Purpose: The aim of this study was to compare the efficacy and safety of the XEN45 gel stent implant in patients with primary open-angle glaucoma or secondary open-angle glaucoma.
A. Ibáñez-Muñoz   +8 more
semanticscholar   +1 more source

Therapy of Open Angle Glaucoma

Archives of Ophthalmology, 1966
A variety of substances are now used in treating open angle glaucoma; their comparative effectiveness needs further study. Pilocaprine has long been the standard beginning therapy for the early form of this disease. However, it has a maximum duration of action of only four to six hours, and its use results in poor control of ocular tensions part of the
F M, Blanton, I P, Pollack
openaire   +2 more sources

Clinical Results of Ab Interno Canaloplasty in Patients with Open-Angle Glaucoma

Clinical Ophthalmology, 2020
Purpose To report treatment outcomes of ab interno canaloplasty using the Visco360 and Omni system devices as a standalone procedure or combined with cataract surgery in patients with open-angle glaucoma (OAG).
T. Hughes, M. Traynor
semanticscholar   +1 more source

Primary open-angle glaucoma

The Lancet, 2004
Primary open-angle glaucoma is a progressive optic neuropathy and, perhaps, the most common form of glaucoma. Because the disease is treatable, and because the visual impairment caused by glaucoma is irreversible, early detection is essential. Early diagnosis depends on examination of the optic disc, retinal nerve fibre layer, and visual field.
Robert N, Weinreb, Peng Tee, Khaw
openaire   +2 more sources

Outcomes of micropulse transscleral cyclophotocoagulation in primary open-angle glaucoma, pseudoexfoliation glaucoma, and secondary glaucoma

European Journal of Ophthalmology, 2020
Purpose: The aim of this study is to compare the outcomes of micropulse transscleral cyclophotocoagulation between primary open-angle glaucoma, pseudoexfoliation glaucoma, and other types of secondary glaucoma.
O. Tekeli, Helin Ceren Köse
semanticscholar   +1 more source

Open-Angle Glaucoma

New England Journal of Medicine, 1993
Our understanding of glaucoma has undergone dramatic changes in the past decade. The ferment has derived from new epidemiologic information, improved diagnostic methods, and developments in surgical and drug therapy. This review concentrates on primary open-angle glaucoma, the most prevalent form of the disorder in Western countries. Definition Primary
openaire   +2 more sources

Home - About - Disclaimer - Privacy